Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terlipressin vs Carbetocin in Laparoscopic Myomectomy
NCT05170230Recruiting
- Sponsor
- Wael Elbanna Clinic
- Start
- Feb 2022
- Primary completion
- Dec 2024
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in uterine leiomyoma comparing Terlipressin, Carbetocin and Placebo (3 arms). Primary endpoint: Change in blood loss at 12 hours. Started Feb 2022; status: recruiting.
02
Drugs
terlipressincarbetocin
03
Conditions
uterine leiomyoma
Beyond the preview
Go deeper on NCT05170230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05170230.